These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30512448)

  • 1. [Exudative age-related macular degeneration: self-monitoring by patients allows for rapid response].
    Girmens JF
    Rev Prat; 2017 Jan; 67(1):101. PubMed ID: 30512448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Age-related macular degeneration diagnosis].
    Maugetfaÿsse M; Wolff B; Sahel JA; Mathis T
    Rev Prat; 2017 Jan; 67(1):92-95. PubMed ID: 30512446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Age-related macular degeneration].
    Sahel JA
    Rev Prat; 2017 Jan; 67(1):87. PubMed ID: 30512444
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low vision rehabilitation in age-related macular degeneration and psychological impacts].
    Robert PY
    Rev Prat; 2017 Jan; 67(1):107-108. PubMed ID: 30512451
    [No Abstract]   [Full Text] [Related]  

  • 5. Is current age related macular degeneration self-monitoring a good tool for detecting exudative recurrence?
    Chamard C; Lacombe S; Navarre S; Rohart C; Daures JP; Allieu S
    J Fr Ophtalmol; 2019 Dec; 42(10):1049-1055. PubMed ID: 31727329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nutritional prevention of age-related macular degeneration].
    Souied É
    Rev Prat; 2017 Jan; 67(1):102-104. PubMed ID: 30512449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of depression in patient with age-related macular degeneration].
    Robert PY
    Rev Prat; 2017 Jan; 67(1):105-106. PubMed ID: 30512450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Real life visual and anatomic outcomes of aflibercept treatment for treatment-naive patients with exudative age-related macular degeneration].
    Duval MV; Rougier MB; Delyfer MN; Combillet F; Korobelnik JF
    J Fr Ophtalmol; 2017 Apr; 40(4):270-278. PubMed ID: 28341388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of age-related macular degeneration].
    Troussard X
    Rev Prat; 2017 Jan; 67(1):96-100. PubMed ID: 30512447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of age-related macular degeneration].
    Delcourt C
    Rev Prat; 2017 Jan; 67(1):88-91. PubMed ID: 30512445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ranibizumab and exudative age-related macular degeneration: 5-year multicentric functional and anatomical results in real-life practice].
    Boulanger-Scemama E; Sayag D; Ha Chau Tran T; Quaranta-El Maftouhi M; Rumen F; Creuzot-Garcher C; Blanco Garavito R; Jung C; Souied E
    J Fr Ophtalmol; 2016 Oct; 39(8):668-674. PubMed ID: 27609025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related macular degeneration: 10 key messages].
    Creuzotgarcher C
    Rev Prat; 2017 Jan; 67(1):109. PubMed ID: 30512452
    [No Abstract]   [Full Text] [Related]  

  • 14. Two year outcome in treatment-naive patients with neovascular age-related macular degeneration (nAMD) using an individualized regimen of Aflibercept.
    Barakat A; Rufin V; Tran THC
    J Fr Ophtalmol; 2018 Sep; 41(7):603-610. PubMed ID: 30166233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting.
    Boulanger-Scemama E; Querques G; About F; Puche N; Srour M; Mane V; Massamba N; Canoui-Poitrine F; Souied EH
    J Fr Ophtalmol; 2015 Sep; 38(7):620-7. PubMed ID: 25913443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of optical coherence tomography performed immediately before intravitreal injection of anti-VEGF in exudative AMD].
    Moyal L; Cohen SY; Pedinielli A; Semoun O; Lalloum F; Jung C; Souied E
    J Fr Ophtalmol; 2015 Sep; 38(7):573-9. PubMed ID: 25997681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.
    Kaya F
    J Fr Ophtalmol; 2017 Dec; 40(10):832-838. PubMed ID: 29113742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of age-related macular degeneration: Expert opinion and therapeutic algorithm].
    Kodjikian L; Fourmaux E; Coscas F; Dumas S; Français C; Morel C; Oubraham H; Razavi S
    J Fr Ophtalmol; 2015 Sep; 38(7):639-45. PubMed ID: 26314897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes.
    Ozkaya A; Alkin Z; Osmanbasoglu OA; Ozkaya HM; Demirok A
    J Fr Ophtalmol; 2014 Apr; 37(4):280-7. PubMed ID: 24657215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management algorithm of age-related macular degeneration with aflibercept: Real-life application].
    Gualino V; Baillif S; Kodjikian L
    J Fr Ophtalmol; 2016 Dec; 39(10):872-879. PubMed ID: 27789040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.